Login to Your Account



3SBio Expands Portfolio With Renal Failure Drug Acquisition

By Cornelia Zou
Contributing Writer

Wednesday, October 30, 2013

HONG KONG – 3SBio Inc. has acquired the patents for a new drug to treat renal failure from the Shanghai Institute of Materia Medica (SIMM) as part of its efforts to expand its offerings linked to diseases of the kidney.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription